| Identification | Back Directory | [Name]
2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid | [CAS]
178554-16-0 | [Synonyms]
2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidi
2-Butyl-1,6-dihydro-4-methyl-6-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetic acid
2-Butyl-1,6-dihydro-4-methyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetic Acid
5-Pyrimidineacetic acid, 2-butyl-1,6-dihydro-4-methyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid
2-(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetic acid | [Molecular Formula]
C25H26N6O3 | [MDL Number]
MFCD34596196 | [MOL File]
178554-16-0.mol | [Molecular Weight]
458.51 |
| Hazard Information | Back Directory | [Uses]
2-Butyl-1,6-dihydro-4-methyl-6-oxo-1-[[2''-(2H-tetrazol-5-yl)[1,1''-biphenyl]-4-yl]methyl]-5-pyrimidineacetic Acid can be used for the characterization of metabolites in human liver microsomes and plasma using quantitative and qualitative analysis. It can also be used for synthesis and antagonists for angiotensin II receptor type 1 (AT1) and for anti-hypertensive activity of pyrimidin-4(3H)-one losartan analogs. |
|
|